投资要点:行情回顾:本周(2025 年12 月1 日- 2025 年12 月5 日)中信医药指数下跌0.7%,跑输沪深300 指数2.0 pct,在中信一级行业分类中排名第22位;2025 年初至今中信医药生物板块指数上涨16.9%,跑赢沪深300 指数0.4pct,在中信行业分类中排名第16 位。本周涨幅前五的个股为:海王生物(+55.6%)、瑞康医药(+36.5%)、粤万年青(+15.4%)、...
Source Link投资要点:行情回顾:本周(2025 年12 月1 日- 2025 年12 月5 日)中信医药指数下跌0.7%,跑输沪深300 指数2.0 pct,在中信一级行业分类中排名第22位;2025 年初至今中信医药生物板块指数上涨16.9%,跑赢沪深300 指数0.4pct,在中信行业分类中排名第16 位。本周涨幅前五的个股为:海王生物(+55.6%)、瑞康医药(+36.5%)、粤万年青(+15.4%)、...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.